{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:38:19Z","timestamp":1791041899287,"version":"4.1.0"},"reference-count":13,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A female patient with Noonan syndrome, attributed to a pathogenic RIT1 variant, presented with white perineal discharge at 8 years and 5 months of age. She had a history of chylothorax and recurrent respiratory infections requiring hospitalization. Discharge analysis revealed 99.5% lymphocytes and elevated triglyceride levels (1939\u2005mg\/dL; 21.9\u2005mmol\/L). Magnetic resonance imaging and contrast-enhanced computed tomography identified lymphatic abnormalities extending from the thoracic to the pelvic region. We suspected that the chylous ascites was being discharged through the genitals. Administration of sirolimus, an mTOR inhibitor, was initiated, leading to a significant reduction in perineal chyle discharge and improved respiratory function with no adverse events. Sirolimus shows promise as a therapeutic intervention for lymphatic abnormalities in patients with Noonan syndrome; however, long-term follow-up is necessary to evaluate its efficacy and safety.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf088","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:16:19Z","timestamp":1745396179000},"source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of Sirolimus in Treating Refractory Lymphatic Malformation in Noonan Syndrome: A Case Study"],"prefix":"10.1210","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8331-7370","authenticated-orcid":false,"given":"Yuka","family":"Nakajima","sequence":"first","affiliation":[{"name":"Division of Pediatric Endocrinology, Metabolism and Nephrology, Children's Medical Center, Osaka City General Hospital , Osaka 534-0021 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9643-7566","authenticated-orcid":false,"given":"Yoh","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Metabolism and Nephrology, Children's Medical Center, Osaka City General Hospital , Osaka 534-0021 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2836-0971","authenticated-orcid":false,"given":"Kohei","family":"Iwata","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Metabolism and Nephrology, Children's Medical Center, Osaka City General Hospital , Osaka 534-0021 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2601-7157","authenticated-orcid":false,"given":"Yuki","family":"Yamada","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Metabolism and Nephrology, Children's Medical Center, Osaka City General Hospital , Osaka 534-0021 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9461-9909","authenticated-orcid":false,"given":"Shinji","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Metabolism and Nephrology, Children's Medical Center, Osaka City General Hospital , Osaka 534-0021 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1271-1577","authenticated-orcid":false,"given":"Jun","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Metabolism and Nephrology, Children's Medical Center, Osaka City General Hospital , Osaka 534-0021 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"1","key":"2025042313222359000_luaf088-B1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/jhg.2015.114","article-title":"Recent advances in RASopathies","volume":"61","author":"Aoki","year":"2016","journal-title":"J Hum Genet"},{"issue":"4","key":"2025042313222359000_luaf088-B2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan syndrome: clinical features, diagnosis, and management guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"2025042313222359000_luaf088-B3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ajmg.a.62529","article-title":"Genotype-cardiac phenotype correlation in a large single-center cohort of patients affected by RASopathies: clinical implications and literature review","volume":"188","author":"Leoni","year":"2022","journal-title":"Am J Med Genet A"},{"issue":"11","key":"2025042313222359000_luaf088-B4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/genes15111463","article-title":"Noonan syndrome: relation of genotype to cardiovascular phenotype-a multi-center retrospective study","volume":"15","author":"Ilic","year":"2024","journal-title":"Genes (Basel)"},{"key":"2025042313222359000_luaf088-B5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1172-2-4","article-title":"Noonan syndrome","volume":"2","author":"Van der Burgt","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2025042313222359000_luaf088-B6","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/humrep\/17.4.1086","article-title":"Increased nuchal translucency is associated with jugular lymphatic distension","volume":"17","author":"Haak","year":"2002","journal-title":"Hum Reprod"},{"issue":"3","key":"2025042313222359000_luaf088-B7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ajmg.a.34438","article-title":"Non-immune hydrops fetalis: a short review of etiology and pathophysiology","volume":"158A","author":"Bellini","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2025042313222359000_luaf088-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000517605","article-title":"Lymphatic abnormalities in noonan syndrome spectrum disorders: a systematic review","volume":"13","author":"Sleutjes","year":"2022","journal-title":"Mol Syndromol"},{"issue":"7","key":"2025042313222359000_luaf088-B9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41591-019-0479-2","article-title":"ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor","volume":"25","author":"Li","year":"2019","journal-title":"Nat Med"},{"issue":"6","key":"2025042313222359000_luaf088-B10","doi-asserted-by":"crossref","first-page":"e20200167","DOI":"10.1542\/peds.2020-0167","article-title":"Severe lymphatic disorder resolved with MEK inhibition in a patient with noonan syndrome and SOS1 mutation","volume":"146","author":"Dori","year":"2020","journal-title":"Pediatrics"},{"key":"2025042313222359000_luaf088-B11","doi-asserted-by":"crossref","first-page":"1335469","DOI":"10.3389\/fmed.2024.1335469","article-title":"Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial","volume":"11","author":"Ozeki","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"2025042313222359000_luaf088-B12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13023-024-03211-z","article-title":"Targeted treatment in complex lymphatic anomaly: a case of synergistic efficacy of trametinib and sirolimus","volume":"19","author":"Seront","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2025042313222359000_luaf088-B13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jvsv.2022.03.017","article-title":"Systematic literature review of lymphatic imaging-guided procedural management of Noonan syndrome","volume":"10","author":"Cox","year":"2022","journal-title":"J Vasc Surg Venous Lymphat Disord"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/6\/luaf088\/62989834\/luaf088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/6\/luaf088\/62989834\/luaf088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T17:22:28Z","timestamp":1745428948000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf088\/8118087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,4,18]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf088","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,4,18]]},"article-number":"luaf088"}}